Opaleye Management Inc. Quant / Systematic

Location: Boston, MA

CIK: 0001595855 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 14, 2020

Total Value: $495M (100.0% shares, 0.0% debt)

Holdings (48)

TARA PROTARA THERAPEUTICS INC 13.1%
Value $64.75M Shares 2,208,472 Est. Cost $30.96 Unrealized 0.0%
OCUL OCULAR THERAPEUTIX INC 10.1%
Value $49.85M Shares 5,984,200 Est. Cost $4.13 Unrealized +60.4%
NEOLEUKIN THERAPEUTICS INC 4.7%
Value $23.24M Shares 1,400,000 Est. Cost $5.58 Unrealized
CHEMOCENTRYX INC 4.2%
Value $20.82M Shares 361,600 Est. Cost $20.86 Unrealized
ETON ETON PHARMACEUTICALS INC 4.0%
Value $19.84M Shares 3,640,000 Est. Cost $6.16 Unrealized -19.4%
APTOSE BIOSCIENCES INC 4.0%
Value $19.75M Shares 3,130,000 Est. Cost $5.04 Unrealized
CDXS CODEXIS INC 3.2%
Value $16.09M Shares 1,400,000 Est. Cost $3.62 Unrealized +211.7%
STXS STEREOTAXIS INC 3.2%
Value $15.66M Shares 3,511,500 Est. Cost $2.93 Unrealized +37.9%
EIDOS THERAPEUTICS INC 3.0%
Value $14.63M Shares 315,550 Est. Cost $22.78 Unrealized
HROW HARROW HEALTH INC 2.9%
Value $14.12M Shares 2,710,000 Est. Cost $4.91 Unrealized 0.0%
MYOVANT SCIENCES LTD 2.8%
Value $14.07M Shares 682,500 Est. Cost $8.06 Unrealized
MGNX MACROGENICS INC 2.8%
Value $13.99M Shares 501,000 Est. Cost $10.71 Unrealized +62.2%
CLDX CELLDEX THERAPEUTICS INC 2.8%
Value $13.92M Shares 1,071,000 Est. Cost $4.43 Unrealized 0.0%
DECIPHERA PHARMACEUTICALS IN 2.6%
Value $13.08M Shares 222,000 Est. Cost $22.57 Unrealized
AVENUE THERAPEUTICS INC 2.3%
Value $11.15M Shares 1,035,000 Est. Cost $5.67 Unrealized
ODONATE THERAPEUTICS INC 2.1%
Value $10.59M Shares 250,000 Est. Cost $24.77 Unrealized
FORTRESS BIOTECH INC 2.1%
Value $10.26M Shares 3,830,000 Est. Cost $2.68 Unrealized
TGTX TG THERAPEUTICS INC 1.8%
Value $8.895M Shares 456,600 Est. Cost $7.37 Unrealized +118.5%
KINIKSA PHARMACEUTICALS LTD 1.8%
Value $8.778M Shares 344,500 Est. Cost $25.48 Unrealized
CERECOR INC 1.8%
Value $8.768M Shares 3,372,500 Est. Cost $2.86 Unrealized
QURE VAXCYTE 1.7%
Value $8.547M Shares 270,400 Est. Cost $48.07 Unrealized +22.9%
BIOHAVEN PHARMACEUTICAL HLDG 1.7%
Value $8.36M Shares 114,350 Est. Cost $73.11 Unrealized
XOMA XOMA CORP DEL 1.7%
Value $8.208M Shares 415,380 Est. Cost $9.47 Unrealized +131.7%
CRNX CRINETICS PHARMACEUTICALS INC 1.5%
Value $7.625M Shares 435,200 Est. Cost $19.70 Unrealized -13.4%
CYTK CYTOKINETICS INC 1.4%
Value $7.143M Shares 303,050 Est. Cost $18.75 Unrealized 0.0%
MOLECULAR TEMPLATES INC 1.4%
Value $6.826M Shares 495,000 Est. Cost $13.29 Unrealized
TRICIDA INC 1.3%
Value $6.548M Shares 238,300 Est. Cost $30.41 Unrealized
CHIMERIX INC 1.3%
Value $6.526M Shares 2,105,000 Est. Cost $3.10 Unrealized
MEI PHARMA INC 1.3%
Value $6.426M Shares 1,556,000 Est. Cost $4.13 Unrealized
FIBROGEN INC 1.1%
Value $5.688M Shares 146,000 Est. Cost $26.18 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 1.1%
Value $5.584M Shares 461,500 Est. Cost $12.03 Unrealized -11.6%
CPRX CATALYST PHARMACEUTICALS INC 1.1%
Value $5.336M Shares 1,155,000 Est. Cost $4.14 Unrealized +8.5%
BIOXCEL THERAPEUTICS INC 1.0%
Value $4.983M Shares 94,000 Est. Cost $53.01 Unrealized
EDAP EDAP TMS SA 0.9%
Value $4.648M Shares 1,878,500 Est. Cost $4.04 Unrealized
KALA PHARMACEUTICALS INC 0.8%
Value $3.794M Shares 361,000 Est. Cost $9.25 Unrealized
CIDARA THERAPEUTICS INC 0.7%
Value $3.582M Shares 970,664 Est. Cost $2.56 Unrealized
LQDA LIQUIDIA TECHOLOGIES INC 0.7%
Value $3.368M Shares 400,000 Est. Cost $7.59 Unrealized 0.0%
ARDX ARDELYX INC 0.7%
Value $3.263M Shares 471,600 Est. Cost $6.95 Unrealized 0.0%
TELA TELA BIO INC 0.7%
Value $3.24M Shares 250,000 Est. Cost $12.84 Unrealized +2.3%
AMARIN CORP PLC 0.6%
Value $3.149M Shares 455,000 Est. Cost $4.04 Unrealized
CRDF CARDIFF ONCOLOGY INC 0.6%
Value $2.956M Shares 590,000 Est. Cost $2.05 Unrealized 0.0%
ADAMAS PHARMACEUTICALS INC 0.5%
Value $2.458M Shares 960,000 Est. Cost $2.56 Unrealized
FENC FENNEC PHARMACEUTICALS INC 0.3%
Value $1.428M Shares 171,000 Est. Cost $7.44 Unrealized 0.0%
ESSA PHARMA INC 0.2%
Value $1.085M Shares 175,000 Est. Cost $6.20 Unrealized
AUTL AUTOLUS THERAPEUTICS PLC 0.2%
Value $962K Shares 60,000 Est. Cost $16.03 Unrealized
ASSERTIO HOLDINGS INC 0.2%
Value $754K Shares 880,000 Est. Cost $0.86 Unrealized
MAGENTA THERAPEUTICS INC 0.1%
Value $385K Shares 51,225 Est. Cost $13.47 Unrealized
BIOLINERX LTD 0.0%
Value $29,000 Shares 16,667 Est. Cost $1.74 Unrealized